CoLU: Confidence-Weighted Layerwise Unlearning for Large Language Models

Large Language Models (LLMs) can memorize and reproduce sensitive, copyrighted, or otherwise undesirable training content, creating privacy, safety, and regulatory concerns. Machine unlearning offers a practical alternative to full retraining, but many existing methods apply broad or fixed parameter updates that can degrade utility and remain brittle under deployment changes such as post-training quantization, where forgotten knowledge may partially re-emerge. We propose Forgetting Only What Matters via Unlearning Layers (FOM-UL), a layer-level unlearning framework that selects transformer layers using a forget-to-retain significance score. This score identifies layers with high influence on the forget set and low sensitivity to the retain set, allowing FOM-UL to concentrate updates where they are most effective while leaving most of the model unchanged. This targeted update strategy improves the forgetting-utility trade-off and provides an empirical path toward quantization-resilient unlearning by reducing the chance that small, diffuse updates are erased by low-bit rounding. Across TOFU, KnowUnDo, and MUSE-style evaluations, FOM-UL reduces residual memorization compared with strong GA, NPO, KLD, SURE, ReLearn, and LUNAR-based baselines while preserving retain-set utility close to the vanilla model. Under 8-bit and 4-bit post-training quantization, FOM-UL maintains stronger memorization suppression and utility preservation than competing methods, and adversarial prompt evaluations show lower recovery of forgotten content. Overall, FOM-UL provides an efficient unlearning strategy that improves targeted forgetting, utility preservation, and deployment robustness without claiming formal guarantees of erasure.

Existing LLM unlearning methods struggle with robustness: unbounded forget losses degrade model coherence, fixed-weight balancing cannot adapt as retain difficulty shifts mid-training, and methods that work on one benchmark falter under scaling or repeated application. We propose BLADE, a constrained bilevel framework whose three mechanisms give smooth, predictable control over the optimization landscape: a clamped-entropy forget loss whose gradient is exactly zero once a token reaches sufficient uncertainty; an asymmetric augmented Lagrangian that permanently ratchets retain protection after any violation; and a bilevel structure confined to LoRA adapters that repairs retain damage before each forgetting step. BLADE dominates across three benchmark families, improving average composite scores over the strongest baselines by $6$% on TOFU, $9$% on MUSE Books, and $7$% on KnowUndo, and it remains stable under $4\times$ scaling and $4$ sequential unlearning steps on MUSE News where the best competing method collapses entirely.

Large language models (LLMs) require effective unlearning to address privacy regulations and safety concerns. However, achieving precise forgetting without compromising general utility remains challenging. Existing sequence- and token-level methods penalize target outputs without modeling their context-dependent retrieval paths, which can disrupt linguistic structure or suppress benign knowledge. We present ADU, a fine-grained, training-based framework that shifts unlearning from token erasure to contextual attention-pathway decoupling. Exploiting the functional distinction between local and global attention heads, ADU identifies preplan positions that retrieve persistent sensitive anchors and fixes their candidate paths under the original model. It then trains attention-projection adapters to suppress attention mass along these paths while preserving local-attention structure and retain-set language modeling. Post-training activation exchange tests whether the modified attention-output module transmits the learned forgetting effect. ADU achieves the strongest aggregate performance among evaluated baselines on the TOFU and WMDP benchmarks, including a Forget Quality of (0.93) on TOFU. It preserves 87--98% of model utility (92.9% on average versus 81.9% for baselines) while reducing side effects in benign contexts.